Disitertide, also known as P144 or P144 Peptide, is primarily used in research focused on fibrosis and tissue remodeling. It has shown potential in inhibiting the activity of transforming growth factor-beta 1 (TGF-β1), a key factor in the development of fibrotic diseases. This makes it a promising candidate for studying conditions such as liver fibrosis, pulmonary fibrosis, and systemic sclerosis. Additionally, its application extends to dermatology, where it is explored for its potential to reduce scarring and improve wound healing by modulating collagen production. Research is ongoing to further understand its therapeutic efficacy and potential clinical applications.